CompletedPhase 1NCT02997969
Safety and Immune Response to a Clade C DNA HIV Vaccine
Studying C syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Mina HosseinipourUNC Project- Lilongwe
- Intervention
- DNA-HIV-PT123 vaccine(biological)
- Enrollment
- 132 enrolled
- Eligibility
- 18-40 years · All sexes
- Timeline
- 2016 – 2018
Study locations (5)
- Aurum Tembisa CRS, Johannesburg, Gauteng, South Africa
- Isipingo CRS, Westville, KwaZulu-Natal, South Africa
- Aurum Institute Klerksdorp CRS, Klerksdorp, North West, South Africa
- National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania
- Matero Reference Clinic CRS, Lusaka, Zambia
Collaborators
HIV Vaccine Trials Network · IPPOX Foundation · Novartis Vaccines
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02997969 on ClinicalTrials.govOther trials for C syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07283900Ascorbate in Myelodysplastic SyndromePrajwal Dhakal
- RECRUITINGPHASE2NCT07505745MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/ObesityHudson Biotech
- RECRUITINGPHASE2, PHASE3NCT06694740Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus PlaceboAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE4NCT06865885LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL LoweringUniversity of California, San Diego
- ACTIVE NOT RECRUITINGNCT06797609Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic SyndromeMario Negri Institute for Pharmacological Research
- RECRUITINGNANCT06528639A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial）Peking University Third Hospital
- ACTIVE NOT RECRUITINGNANCT05497388Efficacy of Serious Game Interventions on HCV Education for HIV PatientsNational Taiwan University Hospital
- RECRUITINGNANCT05390424Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood SpotUniversity Hospital, Rouen